Flagship Pioneering as of March 31, 2020
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 8 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 71.4 | $1.5B | 51M | 29.95 | |
| Rubius Therapeutics | 8.0 | $170M | 38M | 4.45 | |
| Denali Therapeutics (DNLI) | 6.5 | $140M | 8.0M | 17.51 | |
| Kaleido Biosciences Ord (KLDO) | 5.0 | $107M | 17M | 6.15 | |
| Seres Therapeutics | 3.6 | $77M | 22M | 3.57 | |
| Evelo Biosciences | 3.2 | $69M | 18M | 3.76 | |
| Axcella Health Inc equity | 1.4 | $30M | 8.7M | 3.42 | |
| Syros Pharmaceuticals | 0.8 | $17M | 2.9M | 5.93 |
